Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration.
van Cutsem, Gilles
AffiliationInfectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town. firstname.lastname@example.org
MetadataShow full item record
AbstractOBJECTIVES: To introduce the combined South African cohorts of the International epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) collaboration as reflecting the South African national antiretroviral treatment (ART) programme; to characterise patients accessing these services; and to describe changes in services and patients from 2003 to 2007. DESIGN AND SETTING: Multi-cohort study of 11 ART programmes in Gauteng, Western Cape, Free State and KwaZulu-Natal. SUBJECTS: Adults and children (<16 years old) who initiated ART with > or =3 antiretroviral drugs before 2008. RESULTS: Most sites were offering free treatment to adults and children in the public sector, ranging from 264 to 17,835 patients per site. Among 45,383 adults and 6,198 children combined, median age (interquartile range) was 35.0 years (29.8-41.4) and 42.5 months (14.7-82.5), respectively. Of adults, 68% were female. The median CD4 cell count was 102 cells/microl (44-164) and was lower among males than females (86, 34-150 v. 110, 50-169, p<0.001). Median CD4% among children was 12% (7-17.7). Between 2003 and 2007, enrolment increased 11-fold in adults and 3-fold in children. Median CD4 count at enrolment increased for all adults (67-111 cells/microl, p<0.001) and for those in stage IV (39-89 cells/microl, p<0.001). Among children <5 years, baseline CD4% increased over time (11.5-16.0%, p<0.001). CONCLUSIONS: IeDEA-SA provides a unique opportunity to report on the national ART programme. The study describes dramatically increased enrolment over time. Late diagnosis and ART initiation, especially of men and children, need attention. Investment in sentinel sites will ensure good individual-level data while freeing most sites to continue with simplified reporting.
- Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration.
- Authors: Davies MA, Keiser O, Technau K, Eley B, Rabie H, van Cutsem G, Giddy J, Wood R, Boulle A, Egger M, Moultrie H, International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration.
- Issue date: 2009 Oct
- Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.
- Authors: Leroy V, Malateste K, Rabie H, Lumbiganon P, Ayaya S, Dicko F, Davies MA, Kariminia A, Wools-Kaloustian K, Aka E, Phiri S, Aurpibul L, Yiannoutsos C, Signaté-Sy H, Mofenson L, Dabis F, International IeDEA Pediatric Working Group1.
- Issue date: 2013 Feb 1
- Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.
- Authors: Cornell M, Johnson LF, Schomaker M, Tanser F, Maskew M, Wood R, Prozesky H, Giddy J, Stinson K, Egger M, Boulle A, Myer L, International Epidemiologic Databases to Evaluate AIDS-Southern Africa Collaboration.
- Issue date: 2015 Sep
- Estimation of adult antiretroviral treatment coverage in South Africa.
- Authors: Adam MA, Johnson LF
- Issue date: 2009 Sep
- Who is accessing public-sector anti-retroviral treatment in the Free State, South Africa? An exploratory study of the first three years of programme implementation.
- Authors: Wouters E, Heunis C, Ponnet K, Van Loon F, Booysen Fle R, van Rensburg D, Meulemans H
- Issue date: 2010 Jul 1